In this episode, AJEM speaks with <a href="https://www.endocannabinoidmedicine.com/reports/the-future-of-psychedelic-medicine-is-bright/" target="_blank">Henrik Jungaberle, Dr. sc. hum</a>., Executive Director of the Berlin, Germany-based <a href="https://mind-foundation.org/" target="_blank">MIND Foundation</a> about how psychedelic medicine is finally gaining acceptance in the mainstream medical community. He discusses how we are still recovering from the 1960's narrative of ‘seeing psychedelics as super-therapy’ and <a href="https://www.endocannabinoidmedicine.com/features/psychedelic-researchers-emphasize-patient-selection-psychedelic-assisted-therapy/" target="_blank">advocates for well-trained therapists</a> who can see both the pitfalls and potential of psychedelic medicine.    Visit us at <a href="https://www.endocannabinoidmedicine.com/" target="_blank">endocannabinoidmedicine.com</a>
Visit us at <a href="https://www.endocannabinoidmedicine.com/" target="_blank">endocannabinoidmedicine.com</a>

AJEM Live Podcast, Episode 17:  Eric Postow

The American Journal of Endocannabinoid Medicine welcomes you to AJEM Live, interviews with physicians on the frontlines of endocannabinoid medicine and scientists behind the industry's top research trials.